Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC
James E. Frampton
Topics & Concepts
OsimertinibMedicineOncologyInternal medicineAdjuvantLung cancerPopulationAdjuvant therapyEpidermal growth factor receptorStage (stratigraphy)ChemotherapyCancerErlotinibPaleontologyBiologyEnvironmental healthLung Cancer Treatments and MutationsGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies